Each product solves a distinct pricing gap in healthcare: at the point of discharge, at the negotiating table, and at the pharmacy counter. All three are built on the same underlying crosswalk between federal pricing data and clinical, financial ontologies.
Independent practices and hospital finance teams have historically negotiated payer contracts blind, without knowing what the market actually pays for the same services. TruCost changes that. Our rate benchmarking tool pulls exact negotiated rates from public MRF data, giving you the market intelligence to negotiate from a position of knowledge instead of a position of guesswork.
Rather than waiting for a payer's renewal offer and hoping it is fair, a practice administrator can pull up every CPT code in their contract, see the market median for that payer in their county, and walk into a renegotiation with evidence instead of anecdote.
Most patients do not know that paying cash, or using a Patient Assistance Program, can cost dramatically less than using their Medicare Part D coverage. TruCost Drugs surfaces this comparison in real time at the point of prescribing, so clinicians and patients make medication decisions with complete cost clarity. No more choosing between filling a prescription and paying rent.
The tool is architected to extend beyond Medicare Part D, GoodRx, and Cost Plus Drugs to commercial insurer rates as those rates become part of TruCost's broader MRF pipeline, without a schema change on the patient facing side.